← Back to Clinical Trials
Recruiting NCT07195266

NCT07195266 Psychological Outcomes of Strategic Therapy in Adult Outpatients (POST Trial)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07195266
Status Recruiting
Phase
Sponsor Società Scientifica di Psicoterapia Strategica
Condition Mental Disorder
Study Type OBSERVATIONAL
Enrollment 450 participants
Start Date 2021-01-01
Primary Completion 2026-12-31

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Strategic Psychoterapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 450 participants in total. It began in 2021-01-01 with a primary completion date of 2026-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This observational study investigates the outcomes of Strategic Psychotherapy, a form of brief psychological treatment focused on specific goals for change. The aim is to evaluate whether patients who receive this therapy in private practice settings experience improvements in their psychological well-being, psychological symptoms, and daily functioning. The study population includes all adult patients (≥16 years) who spontaneously seek treatment from two strategic therapists between January 2021 and December 2025. Eligible participants must present with psychological problems that meet the criteria for a clinical diagnosis. Participants will complete two psychological questionnaires (SCL-90R and CORE-OM) before starting therapy and again at the end of their treatment. Changes in scores on these outcome measures will be statistically compared with data from a non-clinical population to assess whether the observed changes are greater than would be expected by chance. Additional information will be collected, including medication use, the patient's own evaluation of the therapy, the number of sessions attended, the initial diagnosis, family involvement, and the types of therapeutic prescriptions used.

Eligibility Criteria

Inclusion Criteria: * Adults aged 16 years or older. * Individuals voluntarily seeking psychological treatment in private practice with one of the participating strategic therapists. * Presence of clinically relevant psychological problems consistent with a formal diagnosis (e.g., anxiety disorders, depressive disorders, stress-related conditions, relational difficulties). * Ability to provide informed consent. Exclusion Criteria: * Individuals younger than 16 years. * Patients with severe psychiatric conditions requiring immediate specialized care (e.g., acute psychosis, severe suicidal risk, substance dependence requiring detoxification). * Patients currently enrolled in another clinical trial. * Inability or unwillingness to complete the required questionnaires (SCL-90-R and CORE-OM).

Contact & Investigator

Central Contact

Fabio Leonardi, Psychologist

✉ dott.leonardifabio@gmail.com

📞 0039 3283261083

Principal Investigator

Fabio Leonardi, Psychologist

PRINCIPAL INVESTIGATOR

Private Practice, Livorno (Italy)

Frequently Asked Questions

Who can join the NCT07195266 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, studying Mental Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07195266 currently recruiting?

Yes, NCT07195266 is actively recruiting participants. Contact the research team at dott.leonardifabio@gmail.com for enrollment information.

Where is the NCT07195266 trial being conducted?

This trial is being conducted at Empoli, Italy, Livorno, Italy.

Who is sponsoring the NCT07195266 clinical trial?

NCT07195266 is sponsored by Società Scientifica di Psicoterapia Strategica. The principal investigator is Fabio Leonardi, Psychologist at Private Practice, Livorno (Italy). The trial plans to enroll 450 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology